Genetically Modified T-Cells (CAR-T therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified T-Cells (CAR-T therapy), covering 2024-10-30 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma [Phase 1]